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Phenotypic and Genotypic Evidence for L-Fucose Utilization by
Campylobacter jejuni
Abstract
Campylobacter jejuni remains among the leading causes of bacterial food-borne illness. The current
understanding of Campylobacter physiology suggests that it is asaccharolytic and is unable to catabolize
exogenous carbohydrates. Contrary to this paradigm, we provide evidence for l-fucose utilization by C. jejuni.
The fucose phenotype, shown in chemically defined medium, is strain specific and linked to an 11-open
reading frame (ORF) plasticity region of the bacterial chromosome. By constructing a mutation in fucP
(encoding a putative fucose permease), one of the genes in the plasticity region, we found that this locus is
required for fucose utilization. Consistent with their function in fucose utilization, transcription of the genes
in the locus is highly inducible by fucose. PCR screening revealed a broad distribution of this genetic locus in
strains derived from various host species, and the presence of this locus was consistently associated with
fucose utilization. Birds inoculated with the fucP mutant strain alone were colonized at a level comparable to
that by the wild-type strain; however, in cocolonization experiments, the mutant was significantly
outcompeted by the wild-type strain when birds were inoculated with a low dose (105 CFU per bird). This
advantage was not observed when birds were inoculated at a higher inoculum dose (108 CFU per bird). These
results demonstrated a previously undescribed substrate that supports growth of C. jejuni and identified the
genetic locus associated with the utilization of this substrate. These findings substantially enhance our
understanding of the metabolic repertoire of C. jejuni and the role of metabolic diversity in Campylobacter
pathobiology.
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Campylobacter jejuni remains among the leading causes of bacterial food-borne illness. The current under-
standing of Campylobacter physiology suggests that it is asaccharolytic and is unable to catabolize exogenous
carbohydrates. Contrary to this paradigm, we provide evidence for L-fucose utilization by C. jejuni. The fucose
phenotype, shown in chemically defined medium, is strain specific and linked to an 11-open reading frame
(ORF) plasticity region of the bacterial chromosome. By constructing a mutation in fucP (encoding a putative
fucose permease), one of the genes in the plasticity region, we found that this locus is required for fucose
utilization. Consistent with their function in fucose utilization, transcription of the genes in the locus is highly
inducible by fucose. PCR screening revealed a broad distribution of this genetic locus in strains derived from
various host species, and the presence of this locus was consistently associated with fucose utilization. Birds
inoculated with the fucP mutant strain alone were colonized at a level comparable to that by the wild-type
strain; however, in cocolonization experiments, the mutant was significantly outcompeted by the wild-type
strain when birds were inoculated with a low dose (105 CFU per bird). This advantage was not observed when
birds were inoculated at a higher inoculum dose (108 CFU per bird). These results demonstrated a previously
undescribed substrate that supports growth of C. jejuni and identified the genetic locus associated with the
utilization of this substrate. These findings substantially enhance our understanding of the metabolic reper-
toire of C. jejuni and the role of metabolic diversity in Campylobacter pathobiology.
Campylobacteriosis remains among the leading causes of
bacterial food-borne illness worldwide and is a significant bur-
den to public health due to lost worker productivity, health
care cost, and premature deaths (21). Additionally, Campy-
lobacter infection is a primary antecedent to severe sequelae,
such as Guillain-Barre´ syndrome and Miller-Fisher syndrome.
Campylobacter jejuni, the etiologic agent implicated in the pre-
ponderance of campylobacteriosis cases, is a microaerophilic
thermophile of the class Epsilonproteobacteria that grows best
between 37°C and 42°C. Sources of C. jejuni infection include
contaminated drinking water or milk and contact with infected
pets; however, consumption of undercooked poultry meat is
the most frequent source (34).
Despite recent advances in understanding Campylobacter
physiology, relatively little is known about this organism’s me-
tabolism, particularly within the host. Initial studies reported
that Campylobacter fetus neither ferments nor oxidizes com-
mon carbohydrates (2, 25, 46), and the genus is often deemed
asaccharolytic. Consistent with these observations, the NCTC
11168 genome encodes an incomplete Embden Meyerhof Par-
nas (EMP) pathway due to the absence of phosphofructoki-
nase (36), rendering the organism unable to catabolize exoge-
nous sugars through fructose-1,6-bisphosphate. Interestingly,
pyruvate kinase (pyk) activity can be detected in cell extracts at
high levels, potentially creating a futile cycle among pyruvate,
phosphoenolpyruvate (PEP), and oxaloacetate (49). Vel-
ayudhan and Kelly hypothesize that pyruvate kinase functions
in a catabolic role where its activity is exerted on an unidenti-
fied substrate(s). This enigmatic finding highlights our dearth
of knowledge of Campylobacter physiology, particularly in
terms of growth substrates that confer a metabolic advantage
in different environmental niches.
Several amino acids (Asp, Glu, Ser, Asn, and Pro) are uti-
lized by C. jejuni (16, 26, 32), and mutations to key genes
necessary for their metabolism attenuate C. jejuni’s in vivo
colonization potential (16, 48). In addition to amino acids,
respiratory activity is detected in the presence of 2-ketoacids,
such as pyruvate, 2-ketoglutarate, succinate, and fumarate,
most of which are noted to be citric acid cycle intermediates
(13, 17). The prevailing understanding of C. jejuni’s in vivo
metabolism is centered on amino acids to support growth and
establish colonization of the host intestines. While general
conclusions can be made for isogenic mutants, the metabolic
diversity of C. jejuni is evidenced by amino acid auxotrophs and
differential carbon utilization (12, 13). For example, strain-
specific catabolism of glutathione and asparagine provided ev-
idence of metabolism contributing to tissue tropism (18). Thus,
ancillary metabolic features may present strains with a com-
petitive advantage allowing for the colonization of a broad
range of niches. Although metabolism has not traditionally
been considered a virulence factor, the abilities to survive and
persist in the environment and to cause disease in the host are
predicated on nutrient availability. Therefore, the metabolic
diversity within pathogens may be an overlooked feature of an
organism’s virulence potential.
Indirect evidence of an exogenous carbohydrate playing a
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role in C. jejuni’s physiology was produced by chemotaxis and
cell adherence assays. As a commensal residing primarily in the
mucosal layer of the intestines, C. jejuni demonstrates motility
toward and binds to mucin (20, 31, 45). L-Fucose is a promi-
nent component of eukaryotic glycoproteins and comprises 4
to 14% of the total oligosaccharide component of mucin (3).
Specifically, fucose has been described as a chemoattractant
for C. jejuni (20, 45), increasing flaA promoter activity (3). In
vitro binding of C. jejuni to 1,2-fucosylated glycans has been
demonstrated previously (11, 42), and free fucose reduces ad-
herence to intestinal cells (10), suggesting recognition of this
oligosaccharide by the bacterium. In addition, respiratory ac-
tivity can be detected with fucose as a carbon source (8, 15),
although the assay identified other sugars believed to be false
positives (29).
In this report, we provided evidence of strain-specific utili-
zation of fucose for Campylobacter growth. Furthermore, the
genetic locus for the fucose phenotype (Fuc) was mapped to a
previously described hypervariable plasticity region (PR2)
(38). It was also shown that expression of this genetic locus was
induced by fucose. Chick colonization experiments revealed
that fucose utilization is not essential for Campylobacter colo-
nization of this species but may be advantageous when birds
are exposed to low levels of C. jejuni. Together, these results
identified a new metabolic substrate for C. jejuni, which may
facilitate adaptation of this organism to nutrient-poor condi-
tions.
MATERIALS AND METHODS
Bacterial strains and conditions. Bacterial strains and plasmids used in this
study are listed in Table 1. Escherichia coli DH5 was routinely cultured in
lysogeny broth or on lysogeny agar at 37°C. C. jejuni strains were cultured on
Mueller-Hinton (MH) agar at 37°C microaerobically (85% N2, 10% CO2, 5%
O2) in a gas incubator (model 3130; Forma Scientific, Pittsburgh, PA).
Phenotypic MicroArray. The Phenotypic MicroArray (Biolog, Hayward, CA)
was used according to the manufacturer’s recommendation to identify differen-
tial carbon utilization by C. jejuni strains NCTC 11168, 81116, and 81-176, with
dye mix D as the redox indicator of respiration. Plates were incubated for 48 h
at 42°C microaerobically as described above.
Growth in chemically defined medium. Unless otherwise noted, all chemicals
were acquired from Sigma (St. Louis, MO). For experiments using defined
medium, minimum essential medium (no. 11430-030; Invitrogen, Carlsbad, CA)
was supplemented with FeSO4 (12.5 mg liter1) and ammonium formate (0.3625
mM) to produce basal defined medium (BDM) (pH 7.0 with NaOH). Batch
cultures of the BDM (10 ml) were aliquoted into a sterile 18- by 150-mm glass
tube containing a 10- by 3-mm stir bar and capped with a Morton closure.
Growth substrates were individually added to each tube from 100 stock solu-
tions stored at 20°C. Stock growth substrates included L-fucose (5 M), D-
glucose (5 M), sodium pyruvate (2 M), and a mixture of L-aspartate, L-glutamate,
L-proline, and L-serine (DEPS) at 39 mM, 36 mM, 56 mM, and 130 mM,
respectively. An inoculum (optical density at 600 nm [OD600] of 0.1; 1-cm path
length) was prepared for each strain in the BDM and diluted 1:10, and 100 l of
the diluted inoculum was added to each tube to give an initial cell density of105
CFU ml1. The tubes were placed upright in a custom acrylic tube holder
mounted on a stir plate set at a low setting (230 rpm) and incubated. After 24 h
and 48 h of incubation, 10-fold serial dilutions were prepared in phosphate-
buffered saline (PBS), plated on MH agar, and incubated for 48 h. After incu-
bation, plates were enumerated, and results were recorded and are presented as
log10 CFU ml1. Growth experiments for each strain were repeated on three
separate occasions.
For serial passage experiments, the BDM was supplemented with L-fucose (50
mM final concentration), inoculated at a density of 106 CFU ml1, and grown
with gentle agitation as described above. After incubation for 24 h, 100 l was
inoculated into 10 ml of fresh BDM containing fucose. The freshly inoculated
culture was incubated for 24 h, after which 100 l was inoculated into 10 ml of
fresh BDM containing fucose. This process was repeated two more times for a
total of four serial passages. Serial dilutions of the cultures grown for 24 h were
prepared in PBS and plated on MH agar. The density of the freshly inoculated
culture was estimated from these plate counts. The experiment was repeated
three times.
Construction of fucP mutant. An isogenic fucP mutant was constructed using
an inverse PCR strategy described previously (47). The fucP gene was PCR
amplified with primers fucP_L and fucP_R (Table 2), ligated with pGEM-T
(Promega, Madison, WI), and transformed into chemically competent E. coli
DH5. Recombinant plasmid DNA was isolated and used as a template for
inverse PCR using primers ifucP_L and ifucP_R, deleting an internal fragment
of 512 nucleotides. The cat cassette was PCR amplified from pUOA18 (50) with
the cat_L and cat_R primers. The inverse PCR and cat amplicons were purified
by ethanol precipitation and digested with BglII (New England BioLabs, Ipswich,
MA) according to the manufacturer’s recommendations. The digested antibiotic
cassette and inverse PCR product were ligated and used for transforming E. coli
DH5. For transformation of naturally competent C. jejuni NCTC 11168, puri-
fied recombinant plasmid DNA (pWM10) was diluted to 100 ng l1, spotted (5
l) onto a overnight lawn of C. jejuni, and incubated for 6 h at 37°C. After
incubation, the lawn was harvested and isolates harboring the fucP::cat muta-
tion were selected on MH agar containing chloramphenicol (10 g ml1). Indi-
vidual colonies were streaked for isolation on MH agar containing chloramphen-
icol and incubated at 37°C for 48 h. After incubation, isolated colonies were
plated on MH agar and incubated at 37°C for 24 h. Mutation of fucP and
orientation of the cat cassette were confirmed by PCR. Cells were harvested in
brain heart infusion broth containing 20% glycerol and stored at 80°C.
Complementation of C. jejuni fucP::cat mutation. The fucP::cat mutation
was complemented by inserting fucP and its downstream genes between the
structural genes of the ribosomal gene cluster as described by Karlyshev and
Wren (24), with the following modifications. The ribosomal cluster was amplified
using rrs and rrl primers (24) and cloned into pGEM-T (Promega) to produce
plasmid pRR. pRR was digested with MfeI and ligated with the aphA3 cassette,
which was amplified from pMW10 (51) using primers aphA3_L and aphA3_R.
The resulting plasmid, pRRK, transcribes the aphA3 cassette in the opposite
orientation to the ribosomal genes. pRRK was digested with XbaI and used to
clone the complementing open reading frame(s) (ORF). DNA fragments of
various lengths were amplified from NCTC 11168. In all, four complementation
constructs were created, i.e., fucP, fucP-cj0487, fucP-cj0488, and fucP-aldA con-
structs (see Fig. 1A for details). The left primer, KIfucP_L, served as an anchor
for which different right primers were used (Table 2; Fig. 1A). The fucP, fucP-
TABLE 1. Bacterial strains and plasmids used in this study
Bacterial strain or
plasmid Description or relevant genotype
a Source or
reference
E. coli strain DH5 Plasmid propagation strain Invitrogen
C. jejuni strains
NCTC 11168 Wild-type C. jejuni 36
81116 Wild-type C. jejuni 37
81-176 Wild-type C. jejuni 6
CjWM114a NCTC 11168 derivative,
fucP::cat Cmr
This study
CjWM226a CjWM114a derivative, fucP::cat
rrs::fucP Cmr Kanr
This study
CjWM230a CjWM114a derivative, fucP::cat
rrs::fucP-cj0487 Cmr Kanr
This study
CjWM231a CjWM114a derivative, fucP::cat
rrs::fucP-cj0488 Cmr Kanr
This study
CjWM227a CjWM114a derivative, fucP::cat
rrs::fucP-aldA Cmr Kanr
This study
Plasmids
pGEM-T Cloning vector Promega
pUOA18 E. coli-C. jejuni shuttle vector 50
pMW10 Promoterless lacZ plasmid 51
pfucP pGEM-T::fucP This study
pWM10 fucP::cat Cmr, suicide vector to
construct CjWM114a
This study
pRR pGEM-T::rrs 24
pRRK pRR::aphA3 This study
a Cmr, chloramphenicol resistant; Kanr, kanamycin resistant.
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cj0487, fucP-cj0488, and fucP-aldA ORF fragments were amplified using
KIfucP_R, KIfucP_R4, KIfucP_R5, and KIfucP_R3, respectively. After amplifi-
cation of the ORF fragments, the amplicons were digested with the appropriate
restriction endonuclease (either XbaI or AvrII) and cloned into pRRK. Con-
structs in which the ORF(s) is oriented in the same transcriptional direction as
the ribosomal genes were purified and used as suicide vectors as described above
for mutant construction. Complemented fucP strains were selected on MH agar
containing kanamycin (50 g ml1) and confirmed by PCR.
To assess the effects of the fucP::cat mutation on the transcription of down-
stream genes, an inoculum (OD600 of 1.0) was prepared for strains NCTC 11168
and CjWM226a (see above). One milliliter of this inoculum was added to two 18-
by 150-mm tubes containing 10 ml MH broth and a 10- by 3-mm stir bar. To one
tube for each strain, fucose was added to a final concentration of 25 mM. After
4 h of incubation at 37°C with stirring, RNA was extracted from 1.5 ml of each
culture by use of an RNeasy minikit (Qiagen, Valencia, CA). RNA was DNA-
free (Ambion, Austin, TX) treated and reverse transcribed using 3 pmol of
primers qfucP_RT, cjr01_RT, pcj0487_R, pcj0488_R, and ald_R using Super-
Script RT (Invitrogen) per the manufacturer’s recommendations. The diluted
(1:2) cDNA was used with primers qfucP_L and qfucP_RT, cjr01_L and
cjr01_RT, pcj0487_L and pcj0487_R, tcj0488_L and pcj0488_R, or ald_L and
ald_R (0.4 M each primer) in separate PCR mixtures and cycled for 94°C for
3 min followed by 30 cycles of 95°C for 30 s, 51°C for 30 s, and 72°C for 30 s. PCR
products were detected following electrophoresis through a 1% agarose gel and
staining with ethidium bromide.
Reverse transcription-PCR (RT-PCR) analysis of gene induction by fucose.
To examine the expression of the fucose utilization gene cluster in the presence
or absence of fucose, RNA was extracted from cells grown in defined medium
containing fucose, pyruvate, or DEPS for 48 h using the RNeasy minikit. Nucleic
acid (150 ng) was treated with DNA-free to remove residual DNA. Fifty nano-
grams of DNase I-treated RNA was reverse transcribed with 3 pmol of primers
qfucP_RT, pdapA_R, ald_R, and cjr01_RT (Table 2) using SuperScript RT
(Invitrogen) per the manufacturer’s recommendations. SuperScript RT enzyme
was omitted from control reaction mixtures. The resulting cDNA was diluted 1:2
and used as the template in separate PCR mixtures containing primers
qfucP_RT and qfucP_L, ald_L and ald_R, pdapA_R and tdapA_L, or cjr01_RT
and cjr01_L (0.4 M each primer) and cycled as described above. PCR products
were detected following electrophoresis through a 1% agarose gel and staining
with ethidium bromide.
The relative fucP transcript abundance in wild-type NCTC 11168 was mea-
sured by SYBR green RT-PCR in batch cultures with or without fucose. Over-
night growth on MH agar was harvested using MH broth to an OD600 of 1.0. One
milliliter of this inoculum was transferred to 18- by 150-mm glass test tubes
containing 10 ml of MH broth and a 10- by 3-mm stir bar and capped with a
Morton closure. L-Fucose was serially diluted from a 5 M stock solution and
added to each tube containing MH broth to a final concentration of 0.5 M to
5 mM. After incubation at 37°C for 4 h, RNA was extracted from a 1.5-ml aliquot
using the RNeasy minikit (Qiagen) according to the manufacturer’s recommen-
dation. RNA (150 ng) was treated with DNA-free (Ambion) to remove contam-
inating genomic DNA. cDNA was synthesized from 50 ng of DNA-free-treated
RNA that was reverse transcribed with 3 pmol of gene-specific primers
(qfucP_RT and cjr01_RT) using SuperScript RT (Invitrogen). Reaction mixtures
in which the SuperScript RT enzyme was omitted served as controls. Amplifi-
cation reaction mixtures (25 l) consisted of 1 iQ SYBR green Supermix
(Bio-Rad, Hercules, CA), 10 pmol each of forward and reverse primers, and 2 l
of 1:2-diluted cDNA in duplicate or triplicate technical replicates. Thermocy-
cling parameters were 95°C for 3 min, followed by 35 cycles of 95°C for 30 s, 52°C
for 30 s, and 72°C for 30 s, in a Bio-Rad iQ5 thermocycler. Fluorescence data
were acquired just prior to extension at 72°C. Amplicon melt curve analysis was
added to the end of the run that consisted of continuous fluorescence acquisition
from 65°C to 95°C. Upon completion of the run, the second derivative of the melt
curve was analyzed for spurious peaks and shoulders, indicative of nonspecific
amplification. Additionally, peak symmetry was assessed with melting tempera-
tures (Tm) of 82.3°C and 79.2°C for the 16S and fucP amplicons, respectively.
Background-subtracted fluorescence values were exported as an Excel file (Mi-
crosoft, Redmond, WA) for analysis by LinRegPCR v11.1 software (39) using the
program’s baseline determination algorithm (41). fucP transcript abundance was
normalized to that of the 16S transcript, and the PavrgECt method of efficiency
averaging was applied to determine differences in transcript abundance (23). For
statistical purposes, the ratios of induced/uninduced (Rinduced) values were log2
transformed to yield log2-fold differences. Assumptions of normality and vari-
ance were assessed by the Kolmogorov-Smirnov and modified Levene tests,
respectively. A one-sample t test was applied to test the null hypothesis that
Rinduced equaled 0.
PCR screen for fucP and ggt among field isolates of C. jejuni. To measure the
metabolic diversity among C. jejuni strains, we analyzed the distribution of fucP
and ggt in C. jejuni isolates derived from various host species. The ggt gene
encodes the -glutamyltranspeptidase protein, which has previously been de-
scribed as being strain specific and conferring the ability to utilize glutamine and
glutathione (18). C. jejuni strains isolated from humans, sheep, turkeys, and
chickens were screened for the fucP and ggt genes by PCR. Selected strains were
defined as having at least one band difference by SmaI or KpnI pulsed-field gel
electrophoresis (PFGE) (40). The ggt gene was amplified by primers ggt_L and
ggt_R (0.4 M each) to produce a 285-bp product. The fucP gene was detected
in a separate multiplex reaction using cj0486FWD and cj0486REV (14) and rpoC
and rpsL primers (0.4 M each). The cj0486FWD and cj0486REV primers target
the fucP gene; thus, fucP-positive strains produce a 1.2-kb amplicon. The rpoC
and rpsL primers anneal to the rpoC and rpsL genes, respectively; thus, fucP-
negative strains produce a 446-bp amplicon with the rpoC and rpsL primers due
to the absence of the 9.5-kb gene cluster. This allows for an unambiguous
assessment of the presence/absence of fucP. All reaction mixtures were thermo-
cycled using the parameters for fucP as described earlier (14). To associate the
fucP-positive genotype with the Fuc phenotype, one fucP-positive and one
fucP-negative strain representing each host species were grown in basal defined
medium or defined medium supplemented with fucose (50 mM) or pyruvate (20
mM). The growth experiment for field isolates was performed once for each
isolate. Viable cell numbers were determined after incubation for 24 h as de-
scribed above. The ratio (R) of growth was calculated as the number of viable
cells when grown with substrate divided by the number of viable cells in basal
medium (e.g., Rfucose 	 viable cells when grown with fucose/viable cells in basal
defined medium).
Chick colonization by wild-type and fucP mutant strains. Both mono- and
coinoculation strategies were employed to assess the role of fucose utilization in
intestinal colonization. Day-old chicks (Ross  Cobb) were obtained from a
commercial hatchery and determined to be free of C. jejuni by culture of cloacal
swabs prior to inoculation. Chicks were randomly assigned to three groups. In
experiment I, each bird in groups 1 and 2 (n 	 10 for each group) was orally
TABLE 2. Primers used in this study
Primer name Primer sequence (5
 3 3
)a
fucP_L .............TGACCAAAGAATGTTTGCCTT
fucP_R.............CCACTGGATAATTGCTCCCA
ifucP_L ............CGCAGATCTCATTAAAACTTTGCGCAGCA
ifucP_R............CGCAGATCTATTTATGCTAGGGCGCATTG
cat_L................CGCAGATCTTTCCGTCGTCGGTATCGTAT
cat_R ...............CGCAGATCTGTGCGACAAACTGGGATTTT
rrs.....................CTGGAACTCAACTGACGCTAAG
rrl .....................CTCTTGCACATTGCAGTCCTAC
aphA3_L .........CGCCAATTGCCACAATGATAGAACCAACGA
aphA3_R.........CGCCAATTGATAGGCAGCGCGCTTATCA
KIfucP_L.........CGCTCTAGAGGGCTTGTGCTTTTGCTAAG
KIfucP_R ........CGCTCTAGATGCTCGTGTGCATTACTTCC
KIfucP_R4 ......CGCCCTAGGTCATCTCACAAACCCCTTCA
KIfucP_R5 ......CGCCCTAGGGCGCTAGCTACTCTTGAAATCAC
KIfucP_R3 ......CGCCCTAGGGCAATGGCACCTTTGTTTTT
qfucP_L ...........GGCTTTTAGCGCAGTTTTTG
qfucP_RT........CAATGCGCCCTAGCATAAAT
cjr01_L.............TCCCAGTTCGGATTGTTCTC
cjr01_RT .........GTACAAGACCCGGGAACGTA
pdapA_R.........GCAAAGCAAAACCCATAGGA
tdapA_L ..........GCATAGGTGGAGTTTTTCGAG
ald_L................CCCACATAATGGAGAATTTATCG
ald_R ...............TTCGGCCGTATAATCCATATAA
pcj0487_L........GACGATGAAAAATTAGAGCA
pcj0487_R .......TGCGAAAAACCATCAGGAAT
tcj0488_L.........CAGACATGGCTAAAATGGCA
pcj0488_R .......TTTCCACCATTTTTGTGTGC
cj0486FWD.....GATAGAGCATTAAATTGGGATG
cj0486REV......CCTATAAAGCCATACCAAGCC
ggt_L................GGCGGAATTGCCATAGATGC
ggt_R ...............AGTGCCGTAGCGATCAAGCA
rpoC.................GAACTTGCTATTGCTGAGCC
rpsL..................ACCCTAGTGCAAACTCCCCT
a Added restriction endonuclease sites are underlined.
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challenged with 3  108 CFU of either NCTC 11168 wild type or the fucP
mutant. Birds in group 3 (n 	 10) were challenged with a mixture (1:1) of the
wild type and the mutant strain (1.5  108 CFU of each strain). At 10 and 20
days postinoculation, five birds from each group were humanely sacrificed and
the ceca removed. Contents of the ceca (1 g) were squeezed into a 16- by
100-mm round-bottomed tube, and an appropriate volume of buffered peptone
water (BPW) was added to achieve a 10% (wt/vol) suspension. The sample was
homogenized by vortexing and serially diluted in BPW. Aliquots (100 l) of the
dilution were plated onto duplicate MH agar plates containing growth and
selective supplements (SR0232E and SR0183E; Oxoid, Lenexa, KS) and incu-
bated at 42°C for 48 h microaerobically. For the cocolonization group, aliquots
(100 l) were plated onto both supplemented MH agar and supplemented MH
agar containing chloramphenicol (10 g ml1) in duplicate. Chloramphenicol-
resistant colonies represent the mutant fraction, whereas colonies on MH agar
without chloramphenicol represent the total Campylobacter bacterial number
(i.e., sensitive fraction 	 total fraction  resistant fraction). In experiment II,
chicks were assigned to three groups (n 	 16 per group). Each bird in groups 1
and 2 was inoculated with either the wild type or the mutant strain (1.5  105
CFU), while birds in group 3 served as the cocolonization group (7.5  104
CFU of each strain). At 5 and 10 days postinoculation, eight birds from each
group were sacrificed, the ceca were removed, and C. jejuni bacteria were enu-
merated as described above. For graphical and statistical purposes, the viable
plate counts (CFU/g) were log10 transformed. Differences between strains were
evaluated by a two-sample t test after assessing assumptions of normality and
variance by D’Agostino Omnibus and modified Levene tests, respectively.
RESULTS
L-Fucose supports growth of C. jejuni NCTC 11168 in chem-
ically defined medium. The Phenotypic MicroArray was ini-
tially used to identify carbon substrates metabolized by strains
NCTC 11168, 81116, and 81-176. The ability to reduce the
tetrazolium dye in the presence of L-fucose, glycyl-L-glutamic
acid, and glycyl-L-proline was a metabolic feature distinguish-
ing the three strains (Fig. 2). Since tetrazolium reduction in the
presence of fucose was evident only for strain NCTC 11168,
abiotic reduction of the dye was unlikely, as had been sug-
gested for other sugars (29). Independent confirmation of the
Fuc phenotype was obtained using a chemically defined me-
dium with different supplemented carbon sources (Fig. 3A).
Because formate had been described as a potent electron do-
nor (27), ammonium formate was added to the defined me-
dium as a respiration substrate. No growth was observed in the
basal defined medium (BDM) (no additional carbon source
added) for any of the strains tested, allowing for the detection
of carbon utilization deficiencies. High cell densities (108
CFU ml1) were obtained for all strains when pyruvate was
added to the BDM. Furthermore, like pyruvate, the mixture of
catabolizable amino acids (aspartate, glutamate, proline, and
serine; DEPS) (16) supported high cell densities that were
sustained throughout the experiment, suggestive of common
metabolic pathways for all strains tested. A 3-log10 increase
(P 	 0.00) in viable cell numbers with fucose was evident for
strain NCTC 11168 but not for 81116 or 81-176 at 24 h. Be-
cause NCTC 11168 grew in media containing at least 20 mM
solutes, it is plausible that growth is due to an osmotic imbal-
ance and is not substrate specific. To rule out this possibility,
growth with an equimolar concentration of D-glucose was in-
cluded in three subsequent experiments. Consistent with pre-
vious observations, growth on glucose produced no measurable
increase in viable cell numbers and was similar to that in BDM
FIG. 1. Identification of the genetic locus for fucose utilization. (A) Schematic representation of the chromosomal region associated with the
Fuc phenotype in NCTC 11168. Solid arrows depict open reading frames. Vertical bars indicate locations of frameshift mutations resulting in
premature translational termination. The location of the fucP::cat mutation is indicated by the arrow above fucP. ORFs used to complement the
fucP mutant are indicated by braces below each ORF. The strain designation for each complementing construct is labeled under each respective
brace. The diagonal hatch marks indicate that the entire length of the ORF is not shown. (B) RT-PCR analysis of gene transcription in the
wild-type strain and the fucP::cat strain complemented with fucP (CjWM226a). RT, reverse transcribed with SuperScript RT; RT, no-
SuperScript RT control. Polar effects on transcription of the genes downstream of fucP are evident by the absence of PCR bands in the RT lanes
for cj0487 and aldA in CjWM226a.
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(Fig. 3A) (P 	 0.08). After 48 h of incubation, viability de-
creased in both the BDM and the BDM supplemented with
glucose compared to that at the start of the experiment. In
contrast, growth with pyruvate and DEPS was sustained at high
levels after 48 h. A slight reduction (0.7 log10) in cell viability
was observed for 48 h of growth on fucose; however, viability
was still 1 log10 greater than that at the start of the experi-
ment (P 	 0.01). This reduction in cell viability may be attrib-
uted to exhaustion of the utilizable carbon source or accumu-
lation of nonmetabolizable end products in the batch culture,
prohibiting further growth.
To determine whether fucose would sustain C. jejuni growth,
cultures were serially passaged (1:100) at 24-h intervals in
BDM containing fucose. In all three experiments, C. jejuni
reached cell densities of 7.5 log10 CFU ml
1 after a 24-h
grow-out period from the previous passage (Fig. 3B). Addi-
tionally, the culture could be passaged in fucose-containing
medium at least four times without losing viability, indicating
that fucose is sufficient as a carbon and/or energy source to
maintain viability.
Identification of the genetic locus associated with the Fuc
phenotype. No obvious homologs to the E. coli fucose catab-
olism genes fucR, fucI, fucA, and fucK were evident in any of
the sequenced C. jejuni genomes; however, ORF cj0486 in the
NCTC 11168 genome encodes a protein with significant ho-
mology (E value of 4e64, 38% identity over 91% of the
length of the protein) to the E. coli L-fucose:H symporter
(fucP). This fucP homolog is a member of an 11-ORF cluster
located between the rpoC and rpsL genes (Fig. 1A). Signifi-
cantly, this cluster is present in strain RM1221, which also
displayed the ability to reduce tetrazolium in the presence of
fucose (15), while absent in the genomes of the Fuc strains
81116 and 81-176 (Fig. 3A). The C. jejuni chromosome con-
tains regions that are highly variable or are differentially
present among strains. These regions are considered plasticity
regions (PR), and the 11-ORF cluster containing cj0486 has
previously been characterized as PR2 (38). With the exception
of the 11-ORF cluster, the flanking regions of PR2 in all four
genomes (NCTC 11168, 81-176, 81116, and RM1221) display a
high degree of similarity. Within the PR2 cluster are homologs
to genes encoding an IclR-type transcriptional regulator
(cj0480c), dipicolinate synthase (dapA), altronate dehydratase
(uxaA), a probable membrane transport protein (cj0484), a
possible oxidoreductase (cj0485), a putative fucose permease
(fucP), aldehyde dehydrogenase (aldA), and two proteins of
unknown function (cj0487 and cj0488). uxaA and aldA are
predicted to be pseudogenes due to a frameshift mutation
resulting in a premature stop codon in NCTC 11168 (36).
Similarly, uxaA is predicted to be a pseudogene in RM1221
(35); however, aldA encodes a full-length protein. Partial se-
quencing of aldA and uxaA confirmed the presence of the
predicted premature stop codon in the NCTC 11168 strain
used in this study (data not shown).
The PR2 locus is associated with growth of C. jejuni on
fucose. To assess whether the fucP-containing PR2 locus is
required for growth on fucose, an isogenic mutant was con-
structed by deleting an internal fragment (512 nucleotides) of
fucP and replacing it with a chloramphenicol resistance cas-
sette (cat) (Fig. 1A). The cassette was confirmed by PCR to be
in the same transcriptional orientation to fucP (data not
shown). No growth of the mutant strain was observed when
fucose was added to the defined medium (Fig. 4), indicating a
defect of the mutant in fucose utilization. When pyruvate or
DEPS was added to the medium, the mutant and wild-type
strains demonstrated similar growth levels at 24 and 48 h,
indicating that no other metabolic defects were evident for the
mutant strain.
To complement the growth defect of the fucP mutant, we
first examined whether the fucP mutation affected the expres-
sion of its downstream genes in the PR2 locus. RT-PCR anal-
ysis revealed that disruption of fucP introduced a polar effect
on the transcription of cj0487, cj0488, and aldA, because tran-
scription of the three downstream genes was detected only in
the wild-type strain but not in CjWM226a (partially shown in
Fig. 1B). Thus, a sequential complementation strategy was
employed, where fucP and one, two, or all three downstream
genes were cloned into the fucP mutant background (strains
CjWM230a, CjWM231a, and CjWM227a, respectively) (Fig.
1A). fucP alone (strain CjWM226a) or fucP plus cj0487
(CjWM230a) did not restore the Fuc phenotype (Fig. 4);
however, the Fuc phenotype was partially rescued in
CjWM231a (complemented with fucP, cj0487, and cj0488) and
CjWM227a (complemented with fucP, cj0487, cj0488, and
aldA) (Fig. 4). This complementing effect was particularly ev-
ident after 48 h of incubation, where the mean number of
viable cells was 2.5 log10 greater than that of the mutant strain
when grown with fucose as a carbon source (P 	 0.01). These
results are consistent with the RT-PCR results that polar ef-
FIG. 2. Results of Phenotypic MicroArray carbon utilization plates
(PM1) after incubation for 48 h with strain NCTC 11168, 81116, or
81-176. Wells indicating differential carbon utilization are circled. B4,
L-fucose; G1, glycyl-L-glutamic acid; H1, glycyl-L-proline.
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fects had been introduced by the mutation and suggest that
multiple genes in the locus contribute to the Fuc phenotype.
fucP and other genes in the cluster are transcriptionally
upregulated in the presence of fucose. To determine if genes in
PR2 are inducible by fucose, RT-PCR was used to qualitatively
determine the transcription levels of dapA, aldA, and fucP in
defined medium with different metabolizable substrates. RNA
was extracted from NCTC 11168 cultures grown for 48 h in
defined medium with fucose, pyruvate, or amino acids as the
carbon source. dapA, aldA, and fucP transcripts were amplified
from cells cultured with fucose but not from cells grown with
pyruvate or amino acids (Fig. 5A). Amplification of the 16S
RNA transcript was evident for cells grown under all condi-
tions (Fig. 5A). No amplification of any transcript was detected
when the SuperScript RT enzyme was withheld from the re-
action mixture (control), indicating that genomic DNA
contamination of the RNA is negligible. Furthermore, semi-
quantitative RT-PCR demonstrated a dose-dependent tran-
scriptional response of fucP to fucose. The abundance of the
fucP transcript was significantly greater than that for the un-
induced culture at 50 M fucose (Rinduced 	 5.79; P 	 0.025)
(Fig. 5B) and increased with increasing concentrations of fu-
cose up to 5 mM (Rinduced 	 13.99; P 	 0.000).
FIG. 3. Growth of wild-type C. jejuni strains in defined medium supplemented with different carbon sources. (A) Basal medium was supple-
mented with D-glucose (50 mM), L-fucose (50 mM), sodium pyruvate (20 mM), or a combination of L-aspartate, L-glutamate, L-proline, and
L-serine (DEPS; 390 mM, 360 mM, 560 mM, and 1.3 mM, respectively). White columns, NCTC 11168; gray columns, 81116; black columns, 81-176.
Bars represent the mean viable cell counts  standard errors from three separate experiments. (B) Passage of wild-type NCTC 11168 in defined
medium containing L-fucose (50 mM). Points represent mean viable cell counts  standard errors from three separate experiments. Arrows
indicate passage after 24 h of growth to fresh medium at a 1:100 dilution.
FIG. 4. Growth comparison of various strains in defined medium
supplemented with different carbon sources. White columns, NCTC
11168 wild type; gray columns, fucP derivative of NCTC 11168
(CjWM114a); black columns, fucP::cat strain complemented with
fucP (CjWM226a); dotted columns, fucP::cat strain complemented
with fucP-cj0487 (CjWM230a); diagonally hatched columns, fucP::cat
strain complemented with fucP-cj0488 (CjWM231a); horizontally
hatched columns, fucP::cat strain complemented with fucP-aldA
(CjWM227a). Bars represent the mean viable cell numbers standard
errors from three independent experiments. Growth of the wild-type
strain is shown in Fig. 3 and is included here for comparison.
1070 MURAOKA AND ZHANG J. BACTERIOL.
 o
n
 Septem
ber 22, 2017 by IO
W
A STATE UNIVERSITY
http://jb.asm.org/
D
ow
nloaded from
 
Distribution of fucP among C. jejuni strains and its associ-
ation with the Fuc phenotype. To determine the prevalence
of the fucP gene among C. jejuni strains isolated from different
host species, a PCR screen was applied to strains isolated from
humans, sheep, turkeys, and chickens. Additionally, the ggt
gene was included in the screen, due to its association with the
strain-specific utilization of glutamine and glutathione. Thus,
this PCR assay detects two of the genetic elements that con-
tribute to the known metabolic diversity among C. jejuni
strains. The overall prevalence of fucP was 47%, and the gene
was distributed with parity among host species (Table 3), sug-
gesting that fucose utilization by Campylobacter is not associ-
ated exclusively with certain host species. For all strains tested,
the lack of a fucP band was correlated with the presence of the
rpoC rpsL amplicon, indicating that the fucP gene is gained or
lost with the entire PR2. Overall, ggt was observed at a much
lower frequency (24.4%) than fucP. When strains from each
host species were analyzed separately, the ggt gene was repre-
sented in 47% of human strains, but in only 30%, 8%, and 17%
of strains from turkey, chicken, and sheep sources, respec-
tively. Interestingly, with two exceptions (C. jejuni subsp. doylei
269.97 and C. jejuni 1336), the fucP gene is mutually exclusive
with the ggt gene (i.e., strains are not positive for both fucP ggt)
(Table 3). Two strains (one fucP-negative and one fucP-posi-
tive strain) from each host species were grown in the defined
medium to confirm the association between the Fuc pheno-
type and the presence of fucP. In all strains examined, the
phenotype and genotype association was confirmed (Table 4),
indicating that the presence of fucP (and other genes in PR2)
predicts fucose utilization and that fucose metabolism is not
limited to NCTC 11168.
fucP is not required for colonization of the chick ceca. We
further examined whether fucose utilization is required for
Campylobacter colonization in chickens. Prior to inoculation,
all chicks were free of Campylobacter as determined by cloacal
swab enrichments. In the high-dose experiment (experiment I),
monoinoculated groups were challenged with either the wild-
FIG. 5. RT-PCR analysis of fucose induction of gene expression in
C. jejuni NCTC 11168. (A) Expression of dapA, fucP, and aldA in
wild-type NCTC 11168 in defined medium supplemented with fucose
(50 mM), pyruvate (20 mM), or a mixture of aspartate, glutamate,
proline, and serine (DEPS). RT, RT-PCR with SuperScript RT;
RT, no-SuperScript RT control. (B) Dose-dependent induction of
fucP by fucose. Rinduced represents the relative transcript abundance in
cultures induced with fucose compared to that in uninduced cohorts.
Error bars indicate standard errors from four independent experi-
ments. Values above error bars indicate P values determined by a
one-sample t test.
TABLE 3. Distribution of fucP and ggt among C. jejuni isolates
from turkey, chicken, sheep, and human
Host
species
No. (%) of isolates with indicated genotype/total no. of isolatesa
fucP positive,
ggt negative
fucP negative,
ggt positive
fucP negative,
ggt negative
fucP positive,
ggt positive
Turkey 11/23 (47.8) 7/23 (30.4) 5/23 (21.7) 0/23 (0)
Chicken 11/24 (45.8) 2/24 (8.3) 11/24 (45.8) 0/24 (0)
Sheep 12/24 (50.0) 4/24 (16.7) 8/24 (33.3) 0/24 (0)
Human 7/19 (36.8) 7/19 (36.8) 3/19 (15.8) 2/19 (10.5)b
Total 41/90 (45.5) 20/90 (22.2) 27/90 (30.0) 2/90 (2.2)
a For human clinical isolates, genotypes were determined either by PCR or by
searching available genome sequences. For other host species, genotypes were
determined by PCR.
b The only fucP-positive, ggt-positive isolates were the sequenced strains C.
jejuni subsp. doylei 269.97 and C. jejuni 1336.
TABLE 4. Growth of selected field isolates from different host
species in defined medium supplemented
with pyruvate or fucosea
Host species and
genotype Rfucose Rpyruvate
Turkey
fucP positive 2.77  103 4.92  103
fucP negative 1.64  100 5.35  102
Chicken
fucP positive 2.44  103 9.78  103
fucP negative 5.46  102 9.99  103
Sheep
fucP positive 1.86  103 1.08  103
fucP negative 1.00  100b 1.93  107
Humanc
fucP positive 2.18  104 4.03  104
fucP negative 2.50  101 3.05  106
a Genotypes were determined by PCR. R values were calculated as CFU ml1
with substrate divided by CFU ml1 in basal defined medium (see Materials and
Methods).
b Growth with fucose was below the detection limit (101 CFU ml1).
c The fucP-positive strain is ATCC BAA-223, and the fucP-negative strain is a
clinical isolate from the United States.
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type NCTC 11168 strain or the fucP isogenic mutant at 108
CFU per bird. For the competitive colonization group, a 1:1
mixture of each strain was used to inoculate chicks. Birds were
colonized at high densities throughout the 20-day experiment
(range of 7.50  107 to 5.95  109 CFU/g). For the monoin-
oculated groups, the wild-type strain colonized birds at signif-
icantly higher levels than the fucP mutant at 10 days but not at
20 days postinoculation (P	 0.007 and P	 0.141, respectively)
(Fig. 6A). In contrast, the competition group yielded equivocal
results at 10 days (P 	 0.437), suggesting that no competitive
advantage exists for either strain (Fig. 6A). A slightly (P 	
0.021) greater number of fucP mutant colonies than wild-type
colonies was recovered at the 20-day sampling when strains
were in competition.
To further explore the fitness of the wild-type and fucP
strains, a second colonization experiment was performed at a
lower inoculum dose. For the low-dose experiment (experi-
ment II), birds were challenged with 105 CFU per bird of the
wild-type or mutant strain or a 1:1 mixture of each strain in
competition. For the monoinoculated groups, higher numbers
of the fucP strain than the wild-type strain were recovered
from the ceca 5 and 10 days after inoculation (P 	 0.052 and
P 	 0.018, respectively) (Fig. 6B). In contrast, when in com-
petition, the wild-type strain outcompeted the fucP strain at
both 5 and 10 days postinoculation (P 	 0.014 and P 	 0.005,
respectively) (Fig. 6B). Taken together, the data suggest that
fucose utilization may be advantageous when birds are exposed
to low levels of Campylobacter but is not essential for chick
colonization.
DISCUSSION
Contrary to the dogma that C. jejuni is an asaccharolytic
bacterium, we provide evidence of strain-specific utilization of
fucose, a prominent oligosaccharide component of mucin and
other glycoproteins, to support growth. This conclusion is
based on multiple lines of evidence, including the strain-spe-
cific reduction of a tetrazolium dye in the presence of fucose
(Fig. 2), identification of the genetic locus responsible for the
fucose phenotype (Fig. 1), growth of wild-type, mutant, and
complemented strains in chemically defined medium (Fig. 4),
association of the fucose phenotype with the fucP-positive ge-
notype in various strains (Fig. 3 and Table 4), and induction of
gene expression in the presence of fucose (Fig. 5). These re-
sults have conclusively identified a previously unrecognized
metabolic function in C. jejuni.
The unusual physiology of C. jejuni has contributed to the
paucity of information regarding its metabolic capability and
diversity, and relatively little is known about its growth sub-
strates under various conditions. Amino acids and alternative
electron acceptors play an important role during colonization
(16, 44, 48). These metabolic features are common to the
majority of C. jejuni strains and likely represent the organism’s
primary metabolism. The genetic diversity among strains of C.
jejuni manifests in various secondary metabolic capabilities.
For example, strains expressing -glutamyltranspeptidase are
able to utilize glutathione and glutamine as carbon sources
(18). Furthermore, asparagine can support the growth of
strains that encode an exported form of asparaginase (AnsB)
(18). These types of metabolic diversities may afford a com-
petitive advantage to strains under certain conditions or envi-
ronments. Indeed, the periplasmic form of AnsB allowed C.
jejuni to colonize the liver at significantly higher levels. In this
report, we describe fucose as another substrate that supports
growth in a strain-specific manner.
The Phenotypic MicroArray provides a global perspective of
cellular metabolism in response to a variety of growth condi-
tions. Application of this technology identified D-ribose, L-
FIG. 6. Colonization of chicken ceca by wild-type C. jejuni NCTC 11168 (circles) and its fucP mutant (squares) in mono- and coinoculated
groups. In two separate experiments, young chicks were inoculated with a high dose (108 CFU per chicken) (A) or a low dose (105 CFU per
chicken) (B). In each experiment, birds were inoculated with either a single strain (open symbols) or a 1:1 mixture of the wild type and the mutant
(filled symbols) and sacrificed after 5, 10, or 20 days postinoculation (DPI). Each point represents data from a single bird. A horizontal bar indicates
the mean for each group. P values above paired groups reflect significance as determined by a two-sample t test.
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lyxose, D-xylose, and L-arabinose as carbohydrates with which
an abiotic reduction of tetrazolium was evident (Fig. 2, wells
C4, H6, B8, and A2, respectively) (29). The response to these
pentose sugars is likely an artifact of microaerobic incubation
at an elevated temperature producing an abiotic reduction of
the tetrazolium dye (7, 29). Others have reported tetrazolium
reduction with arabinose but have also described fucose as a
possible utilizable monosaccharide (8, 15). In this study, we
identified this phenotype in strain NCTC 11168; however, the
fucose phenotype (Fuc) was not observed with strains 81116
and 81-176 (Fig. 2), suggesting that biological metabolism of
this deoxyaldohexose is responsible for the color change. In-
dependent confirmation of this distinguishing phenotype was
obtained using a nutrient defined medium (Fig. 3A). Further-
more, fucose was sufficient as a carbon and/or energy source to
maintain growth and viability after four serial passages in the
defined medium (Fig. 3B). This report is the first description of
a carbohydrate as a carbon and/or energy source sustaining C.
jejuni growth.
Whole-genome microarrays estimate the genetic variability
among C. jejuni strains to be 16.3% (38), and the strain-specific
metabolism of fucose would likely be associated with genomic
plasticity regions. Genomic plasticity regions (PR) are charac-
terized as gene clusters that are hypervariable or vary in pres-
ence among strains. The genetic locus associated with the Fuc
phenotype was localized to a 9.5-kb region in the chromosome
of NCTC 11168 between two highly conserved genes (rpoC and
rpsL). In Fuc strains (e.g., 81116 and 81-176), the 9.5-kb ORF
cluster is absent, consistent with the characterization of this
region of the chromosome as PR2 (38). Mutation of the pre-
dicted fucose permease gene (fucP) rendered the mutant strain
unable to utilize fucose in defined medium. As demonstrated
by RT-PCR (Fig. 1B), the fucP::cat mutation caused a polar
effect on the transcription of genes downstream of fucP in the
PR2 cluster. Thus, it is not surprising that the Fuc phenotype
could not be restored by reconstituting the fucP gene alone.
The phenotype was partially rescued by complementation of
the fucP, cj0487, and cj0488 genes, suggesting that multiple
genes in the PR2 gene cluster are necessary for the phenotype.
The reason that full restoration of the phenotype was not
achieved may be due to expression levels of the complemented
genes. In the wild-type strain, gene expression is significantly
induced in the presence of fucose; however, this increase in
transcript abundance would not occur in the complemented
strain, since the native promoter was not included in the con-
struct. Alternatively, disruption of the fucP gene may destabi-
lize the entire transcript, causing reduced expression of genes
upstream of the mutation. Cj0487 shows homology to an
amidohydrolase from Gardnerella vaginalis (E value of 7e22),
while Cj0488 displays similarity to the Bacillus subtilis L-rham-
nose mutarotase (E value of 1e05). The function of these
genes and their contribution to the Fuc phenotype warrant
further investigation, especially considering the lack of ho-
mologs to previously described fucose catabolism genes, as
discussed below.
Because C. jejuni responds dynamically to environmental
cues, it is possible that the genes necessary for fucose metab-
olism are differentially regulated depending on substrate avail-
ability. Qualitative RT-PCR revealed that fucP, dapA, and
aldA transcripts were observed in the presence of fucose but
not with pyruvate or amino acids (Fig. 5A). Semiquantitative
RT-PCR data estimated the fucP transcript abundance to be
significantly increased in cultures with added fucose compared
to that in uninduced cultures (Fig. 5B). This response was dose
dependent, suggestive of a transcriptional regulatory mecha-
nism that was responsive to fucose. Interestingly, the first gene
(cj0480c) in the 11-ORF cluster is predicted to encode a 253-
amino-acid protein with similarities to a DNA binding protein
of the IclR-type regulator family (36). IclR-type transcriptional
regulators are known to be involved in the regulation of several
metabolic processes and are capable of binding effector mol-
ecules which affect DNA binding (33). Whether Cj0480c is
involved in regulation of fucose utilization in Campylobacter is
being investigated in our laboratory.
Fucose utilization has been described for both pathogenic
and commensal bacteria, including Salmonella enterica serovar
Typhimurium LT2, Escherichia coli, Klebsiella pneumoniae,
Roseburia inulinivorans, and Bacteroides thetaiotaomicron (4, 5,
9, 19, 43). Under both anaerobic and aerobic conditions, fu-
cose is metabolized to dihydroxyacetone phosphate (DHAP)
and L-lactaldehyde by the key enzymes fucose isomerase, fu-
culose kinase, and fuculose aldolase (FucI, FucK, and FucA,
respectively) (9). Particularly enigmatic is the notable absence
of FucI, FucK, and FucA homologs in the sequenced C. jejuni
genomes. DHAP is metabolized to pyruvate through phos-
phoenolpyruvate in the lower portion of the Embden Meyer-
hof Parnas (EMP) pathway. Interestingly, the genome se-
quence of C. jejuni predicts that the genes necessary for the
conversion of DHAP to pyruvate are intact (36), supporting
Velayudhan and Kelly’s hypothesis that the lower portion of
the EMP pathway functions in a catabolic role for an uniden-
tified substrate (49). Pyruvate kinase (pyk) plays an important
function in the catabolic role of glycolysis, catalyzing the trans-
fer of a phosphate group from PEP to ADP, yielding pyruvate
and ATP. Whether carbons from fucose contribute to DHAP
formation in Campylobacter is currently under investigation in
our laboratory.
Under aerobic conditions, E. coli oxidizes lactaldehyde to
lactate through the activity of aldehyde dehydrogenase (9).
Within the 11-ORF cluster of the Fuc locus, an aldehyde
dehydrogenase homolog is present; however, a frameshift mu-
tation introduces a predicted premature stop codon that trun-
cates the protein at the amino terminus, producing a 73-amino-
acid N-terminal fragment and a 393-amino-acid C-terminal
fragment (36). By sequencing the region containing the pre-
mature stop codon, we confirm that aldA and uxaA contain the
predicted premature stop codons in the NCTC 11168 strain
used in this study, although no functional enzymatic assays
were performed to assess activity of the truncated proteins. In
the absence of oxygen, lactaldehyde is reduced to 1,2-pro-
panediol by propanediol oxidoreductase (5), which is either
excreted (4) or fermented to propionate and propanol (5, 43).
A BLAST query using the amino acid sequence of propanediol
oxidoreductase from E. coli produced one significant hit to a
hypothetical protein in strain 81116 (27% identity, E value of
5e23) but no hits in the NCTC 11168 or other C. jejuni
genomes. In addition, no homologs of fucI, fucK, or fucA genes
were identified in C. jejuni NCTC 11168 when the E. coli
orthologs were used in a BLAST query. Based on these ho-
mology searches, it appears that C. jejuni may catabolize fucose
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through an uncharacterized and potentially novel pathway.
More work to elucidate the pathway of fucose utilization by C.
jejuni is warranted, considering the apparent lack of known or
previously identified enzymes necessary for fucose dissimila-
tion.
Strain-specific secondary metabolism could confer an advan-
tage in the colonization of different host species. To explore
this possibility, strains from chicken, turkey, human, and sheep
sources were screened for the fucP and ggt genes by PCR. Since
all currently sequenced genomes position the PR2 gene cluster
between rpoC and rpsL, the inclusion of rpoC and rpsL primers
in the fucP multiplex reaction mixture ensures that allelic poly-
morphism at the primer binding site(s) does not produce a
false-negative result. This strategy, however, does not preclude
the possibility of a false negative due to the joint chance of
allelic divergence at the primer binding site(s) and transloca-
tion of the gene due to intramolecular recombination. A pre-
vious study assessing the distribution of fucP among isolates of
poultry and human origin estimated the prevalence of the gene
at 64.5% (14). Here, we report the overall prevalence of fucP
to be 47.7%, a slightly lower estimate than reported earlier
(14). This discrepancy may be due to the sampling strategy
employed to identify the isolate population. In this study, the
use of PFGE-defined strains ensured that isolates were genet-
ically distinct from one another and that a single clonal strain
is not overrepresented in the sample population. No associa-
tion between the fucP-positive genotype and host species ex-
amined in this study was observed. Additionally, the fucP gene
is distributed with parity among human-derived strains origi-
nating from Asia, South Africa, the United States, and the
United Kingdom. A more comprehensive sampling, however,
is required to assess any spatial effects on the distribution of
the fucP gene. With two exceptions (C. jejuni subsp. doylei
269.97 and C. jejuni 1336), the fucP and ggt genes appear to be
mutually exclusive, which suggests vertical dissemination and
divergence from a common ancestor. Alternatively, the two
genes may be functionally incompatible in the same cell.
The selective pressures involved in the maintenance of the
Fuc phenotype remain undefined but likely include nutrient
availability. How C. jejuni obtains free fucose from its micro-
environment remains unknown. The human commensal Bac-
teroides thetaiotaomicron induces intestinal cells of the host to
produce more fucosylated glycans, directly affecting nutrient
availability (19). Additionally, patients infected with C. jejuni
expressed Muc1 at higher levels than uninfected cohorts (28);
thus, C. jejuni may also be capable of inducing host intestinal
cells to produce fucosylated glycans. Several bacteria secrete
fucosidase, which cleaves the terminal fucose from the glyco-
sylated protein, producing free fucose which can subsequently
be taken up. Although no fucosidase homolog was identified in
the C. jejuni genome, it is plausible that intestinal commensals
produce the enzyme to cleave the fucose from the host glyco-
conjugate. Alternatively, Helicobacter pylori, a close relative of
Campylobacter, has been shown to direct host cells to produce
-L-fucosidase, freeing the fucose from the glycoconjugate di-
rectly (30). Secreted mucin has been suggested to increase the
viability of C. jejuni (1), indicating that C. jejuni is capable of
directly degrading or inducing the host to degrade mucin into
components that support growth. The structure of the fucosy-
lated glycan may vary among species, due to differences in the
fucosyltransferases that modify the protein. Differences in the
glycan structure may confer a species adaptation of Fuc
strains, although our survey of chicken, turkey, sheep, and
human strains did not identify the fucP gene as overly repre-
sented in any particular host examined in this study.
The chick colonization model was used to assess the coloni-
zation potential and competitive fitness of the wild-type strain
and an isogenic Fuc mutant. Birds inoculated with the mutant
strain displayed high C. jejuni densities in the ceca, indicating
that fucose utilization is not essential for chicken colonization.
This is consistent with the proportion and isolation of Fuc
strains from chickens and turkeys. The competition model of
colonization yielded equivocal results, depending on the inoc-
ulation dose and duration of colonization. These results sug-
gest that fucose utilization may be advantageous but is not
essential for the colonization of the chick intestine. This is
likely due to the presence of amino acids in the chicken intes-
tinal tract, which are preferred substrates for Campylobacter
metabolism, overshadowing the role of fucose utilization in
colonization. However, it may be possible that Fuc strains of
C. jejuni have a competitive advantage in another host species
due to variation in nutrient availability (e.g., amino acids),
microbiome, and structural differences of host mucin. Interest-
ingly, transposon mutagenesis identified fucP as an invasion
determinant, since transposon insertion in this gene led to
reduced invasion of cultured cells (22). How fucP contributes
to the invasion process is unknown, but the finding illustrates
the functional diversity of this gene.
The findings reported here identified a carbohydrate sub-
strate that supports C. jejuni growth and formally linked this
phenotype to the Fuc locus localized to a plasticity region of
the Campylobacter chromosome. The Fuc phenotype likely
involves adaptation to nutrient-poor niches where utilization
of this carbon and/or energy source affords the organism a
competitive advantage. How C. jejuni metabolizes fucose and
how this metabolic pathway interacts with other processes in
facilitating Campylobacter adaptation remain to be elucidated
in future studies.
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